Ann: Quarterly Activity Report and Appendix 4C, page-36

A Blue-chip tracking device for these eski's would seem like a no brainer - however I would of thought that a licensing deal etc. would have been announced by now if that was the case.

Josh Frydenberg promoting an Australian patented tech that is so pertinent to the logistics of this vaccine would be such a boon for Australia and put the spotlight of the world on us as a company and lead to other sales... as a shareholder I want to hear from BCT Management as to what they are doing around this space - if it's not viable or has been rejected at least tell us so we know that they tried.

In my humble opinion a good company would be forcing themselves into the conversation by any means possible and very publicly - and keep shareholders in the loop with weekly announcements... it's very frustrating to go months without any idea of BCT involvement in this vaccine arena.